Cargando…
Lodoxamide Attenuates Hepatic Fibrosis in Mice: Involvement of GPR35
A previous pharmacogenomic analysis identified cromolyn, an anti-allergic drug, as an effective anti-fibrotic agent that acts on hepatocytes and stellate cells. Furthermore, cromolyn was shown to be a G protein-coupled receptor 35 (GPR35) agonist. However, it has not been studied whether anti-fibrot...
Autores principales: | Kim, Mi-Jeong, Park, Soo-Jin, Nam, So-Yeon, Im, Dong-Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939691/ https://www.ncbi.nlm.nih.gov/pubmed/31189299 http://dx.doi.org/10.4062/biomolther.2018.227 |
Ejemplares similares
-
O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice
por: Kang, Saeromi, et al.
Publicado: (2021) -
The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015) -
Involvement of CXCL17 and GPR35 in Gastric Cancer Initiation and Progression
por: Li, Yizhi, et al.
Publicado: (2022) -
GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
por: Im, Dong-Soon
Publicado: (2021) -
Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science
por: Son, So-Eun, et al.
Publicado: (2021)